1. Home
  2. KROS vs SCVL Comparison

KROS vs SCVL Comparison

Compare KROS & SCVL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • KROS
  • SCVL
  • Stock Information
  • Founded
  • KROS 2015
  • SCVL 1978
  • Country
  • KROS United States
  • SCVL United States
  • Employees
  • KROS N/A
  • SCVL N/A
  • Industry
  • KROS Biotechnology: Pharmaceutical Preparations
  • SCVL Clothing/Shoe/Accessory Stores
  • Sector
  • KROS Health Care
  • SCVL Consumer Discretionary
  • Exchange
  • KROS Nasdaq
  • SCVL Nasdaq
  • Market Cap
  • KROS 565.0M
  • SCVL 608.5M
  • IPO Year
  • KROS 2020
  • SCVL 1993
  • Fundamental
  • Price
  • KROS $15.17
  • SCVL $17.61
  • Analyst Decision
  • KROS Buy
  • SCVL Hold
  • Analyst Count
  • KROS 14
  • SCVL 1
  • Target Price
  • KROS $20.56
  • SCVL N/A
  • AVG Volume (30 Days)
  • KROS 1.1M
  • SCVL 347.7K
  • Earning Date
  • KROS 11-06-2025
  • SCVL 11-20-2025
  • Dividend Yield
  • KROS N/A
  • SCVL 3.37%
  • EPS Growth
  • KROS N/A
  • SCVL N/A
  • EPS
  • KROS 0.47
  • SCVL 2.27
  • Revenue
  • KROS $232,844,000.00
  • SCVL $1,153,927,000.00
  • Revenue This Year
  • KROS $6,657.47
  • SCVL N/A
  • Revenue Next Year
  • KROS N/A
  • SCVL $2.07
  • P/E Ratio
  • KROS $32.70
  • SCVL $7.85
  • Revenue Growth
  • KROS 85820.30
  • SCVL N/A
  • 52 Week Low
  • KROS $9.12
  • SCVL $16.14
  • 52 Week High
  • KROS $72.37
  • SCVL $39.29
  • Technical
  • Relative Strength Index (RSI)
  • KROS 49.12
  • SCVL 30.94
  • Support Level
  • KROS $14.86
  • SCVL $17.71
  • Resistance Level
  • KROS $15.30
  • SCVL $19.48
  • Average True Range (ATR)
  • KROS 0.58
  • SCVL 0.56
  • MACD
  • KROS 0.02
  • SCVL -0.13
  • Stochastic Oscillator
  • KROS 72.85
  • SCVL 0.00

About KROS Keros Therapeutics Inc.

Keros Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for patients suffering from hematological, pulmonary, and cardiovascular disorders with high unmet medical needs. The company's protein therapeutic product candidate, KER-050, is being developed for the treatment of low blood cells counts, or cytopenias, including anemia and thrombocytopenia, in patients with myelodysplastic syndromes, or MDS, and in patients with myelofibrosis.

About SCVL Shoe Carnival Inc.

Shoe Carnival Inc is a family footwear retailer that offers a broad assortment of dress, casual, and athletic footwear for men, women, and children with an emphasis on national name brands such as Nike, Skechers, Adidas, Puma, HEYDUDE, Converse, Vans, and Crocs. The company operates its business as one reportable segment based on the similar nature of products sold; merchandising, distribution, and marketing processes involved; target customers; and economic characteristics of stores and e-commerce platforms. Its bricks-first, omnichannel approach provides customers easy access to a wide assortment of branded footwear for work, athletics, daily activities, and special events via a choice of delivery channels.

Share on Social Networks: